A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.

Specifically, in the PRRT-naive cohort, the ORR reached 60%, while 34.1% of patients showed stable disease. Combining these ...

The Dounreay site, opened about 70 years ago as the United Kingdom's hub for fast reactor research, has been undergoing decommissioning since the 1990s. The Office for Nuclear Regulation had ...

This engineering exam, which is a gateway to some of the premium engineering colleges such as IITs, NITs and more, cover ...

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. is conducting a ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

Scientists are questioning whether humanity can truly “dim the Sun” without causing chaos. A new University study shows that ...

Discover key insights from Luxfer Holdings’ Q3 2025 earnings call, including raised guidance, strong aerospace and defense growth, and major ...

Scientists have taken another giant step towards building the most precise clock ever imagined—one that could display not only the passage of time, but shifting rules of nature itself. An ...

A 3D model of the Sea of Japan reveals a three-layer vertical structure of PCBs, with dissolved PCB concentrations peaking at intermediate depths ...

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. (CATX) is conducting ...

BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...